Research & Development
Cardiovascular: Page 2
Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing
The Chicago-based digital health company is leveraging artificial intelligence and multisensor devices to develop tools that enable the early detection of cardiovascular disease.
December 8, 2022
‘Good’ cholesterol worse for some adults: NIH study
In the study, lower levels of "good" cholesterol were associated with increased risks for heart attacks for white but not Black adults.
November 23, 2022
Physician, medical office to pay more than $2.6M involving clinical lab kickbacks
Feel Well Health and its owner violated the Anti-Kickback Statute by receiving remuneration from Boston Heart Diagnostics for clinical laboratory services for Medicare patients, according to the DOJ.
November 15, 2022
Roche points to results of heart failure study leveraging its cardiac hormone biomarker and test
The results were shared this week at an American Heart Association Late-Breaking Scientific Session and published simultaneously in the Lancet.
November 9, 2022
ACC, AHA issue aortic disease guideline, recommend genetic screening
The guidelines include genetic testing of first-degree relatives of individuals with thoracic aortic disease, as well as an emphasis on surgical thresholds, imaging, and multidisciplinary aortic teams.
November 3, 2022
UK Biobank study links COVID-19 infection with poor cardiovascular health
Individuals who have been hospitalized because of COVID-19 infection have a higher risk of experiencing adverse cardiovascular health outcomes, according to a UK Biobank study.
October 27, 2022
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
Simple blood test can detect PTSD biomarkers
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Illumina NGS software to enable tertiary analysis for oncology, rare disease
Serum protein in study predicted which patients might die without a liver transplant
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
Epigenetics testing firm Cardio Diagnostics goes public on Nasdaq
At the core of its cardiovascular solutions is the Integrated Genetic-Epigenetic Engine, developed at the University of Iowa.
October 26, 2022
AI-enabled retina imaging could predict cardiovascular disease, death
The method could enable the development of a noninvasive test to screen people who are at medium-to-high risk of circulatory disease.
October 14, 2022
Daxor highlights study on test in heart failure management
Daxor highlighted results of a study from Duke Heart validating the utility of the firm's diagnostic blood test in optimizing the therapeutic management of heart failure patients.
October 3, 2022
Nordic touts PRO-C6 biomarker for heart failure clinical trials
In collaboration with Bristol Myers Squibb and the University of Pennsylvania, researchers combined analyses of six independent cohorts of HFpEF patients from around the globe, which are being evaluated with the PRO-C6 biomarker.
September 13, 2022
Boston Heart Diagnostics launches polygenic risk map
The risk map leverages polygenic risk scores (PRS) to provide physicians with an understanding of a patient's absolute genetic risk of complex disease, allowing for the creation of early, personalized intervention strategies, the firm said.
September 12, 2022
Week in Review: At-home flu testing, asymptomatic monkeypox, telediagnostic accuracy, and more
Dear LabPulse.com member,
September 7, 2022
Page 2 of 6